This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medbox Updates Financial Projections

HOLLYWOOD, Calif., Nov. 23, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) ( www.medboxinc.com), updated their financial projections for the periods through 2016. The move came after the recent votes in the states of Colorado and Washington to legalize marijuana, and a flood of requests for assistance came into Medbox from operators and potential operators in those states, looking for guidance on how to run a successful, legal and fully compliant business in this newly opened industry. As the national leader in providing consulting services and products to the medical marijuana industry, Medbox is poised to significantly increase revenues due to these recent voter referendums.

Additionally, Medbox is targeting a new market niche, by providing their patented medicine dispensing systems to hospice care institutions. The company also provides products and services to the traditional retail pharmacy industry.

Accordingly, company management adjusted their long-term financial projections upward to reflect this new business environment.  

The revised projections show over $6 million in increased revenue for fiscal year end 2013 (from $10.7m to $16.9m), with subsequent increases through the next 3 years, culminating in a leap from initial projections of $48.6 million by end of fiscal year 2016 - up to a hefty $72.7 million.

Dr. Bruce Bedrick, CEO of Medbox, Inc., stated that revised projections are still conservative and reflect modest expectations of company growth. "We are in the right business, at the right time, with the right products and the right services," Bedrick commented. "Our anticipated growth is happening faster than initial forecasts, but is completely in line with market conditions and demand."

The updated projections, along with other company news, can be found at:   http://www.thedispensingsolution.com/news

For more information, contact Medbox Investor Relations at: (800) 762-1452.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs